The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas
- PMID: 25316295
- DOI: 10.1007/s00259-014-2914-4
The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas
Erratum in
-
Erratum to: The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):360-1. doi: 10.1007/s00259-014-2968-3. Eur J Nucl Med Mol Imaging. 2015. PMID: 25492805 No abstract available.
Abstract
Purpose: To retrospectively study the influence of nodal tumour burden on lymphoscintigraphic imaging in 509 consecutive patients with melanomas.
Methods: Bidirectional lymphatic drainage, the clear depiction of an afferent lymphatic vessel, time to depiction of the first sentinel lymph node (SLN) and number of depicted and excised nodes were recorded. Nodal tumour load was classified as SLN-negative, SLN micrometastases or macrometastases.
Results: In the overall population, using multivariate regression analysis, a short SLN depiction time was significantly associated with the depiction of a greater number of radioactive nodes, a short distance between the primary tumour site and the nodal basin, younger age and lower nodal tumour burden. The proportion of patients with clear depiction of an afferent lymphatic vessel depended on the nodal tumour load (46% in SLN-negative patients, 57% in SLN positive patients, and 69% in patients with macrometastases; P = 0.009). Macrometastasis was significantly associated with delayed depiction of the first radioactive node and a greater number of depicted hotspots. In patients with clinically nonsuspicious nodes, i.e. the classical target group for SLN biopsy, clear depiction of an afferent vessel was significantly associated with a higher number of SLNs during dynamic acquisition, SLN micrometastasis and a higher overall number of metastatic lymph nodes after SLN biopsy plus completion lymphadenectomy. The excision of more than two SLNs did not increase the metastasis detection rate. In patients with bidirectional or tridirectional lymphatic drainage, the SLN positivity rates for the first, second and third basin were 25.4%, 11.7% and 0.0 %, respectively (P = 0.002).
Conclusion: In patients with clinically nonsuspicious lymph nodes, clear depiction of an afferent lymph vessel may be a sign of micrometastasis. Macrometastasis is associated with prominent afferent vessels, delayed depiction of the first radioactive node and a higher number of depicted hotspots.
Similar articles
-
Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.Laryngoscope. 2001 Aug;111(8):1366-72. doi: 10.1097/00005537-200108000-00010. Laryngoscope. 2001. PMID: 11568570
-
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.J Nucl Med. 1999 Jul;40(7):1143-8. J Nucl Med. 1999. PMID: 10405134
-
Cutaneous lymphatic drainage in patients with grossly involved nodal basins.Ann Surg Oncol. 1999 Jun;6(4):345-9. doi: 10.1007/s10434-999-0345-4. Ann Surg Oncol. 1999. PMID: 10379854
-
Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.J Eur Acad Dermatol Venereol. 2000 Jan;14(1):35-45. doi: 10.1046/j.1468-3083.2000.00005.x. J Eur Acad Dermatol Venereol. 2000. PMID: 10877250 Review.
-
Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.J Surg Oncol. 2004 Mar;85(3):141-51. doi: 10.1002/jso.20027. J Surg Oncol. 2004. PMID: 14991886 Review.
Cited by
-
The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.Mod Pathol. 2021 Oct;34(10):1839-1849. doi: 10.1038/s41379-021-00835-5. Epub 2021 Jun 15. Mod Pathol. 2021. PMID: 34131294 Free PMC article.
-
Melanocytic nevi in sentinel lymph nodes: association with cutaneous nevi and clinical relevance in patients with cutaneous melanomas.J Cancer Res Clin Oncol. 2022 Nov;148(11):3125-3134. doi: 10.1007/s00432-021-03894-y. Epub 2022 Jan 20. J Cancer Res Clin Oncol. 2022. PMID: 35059868 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical